Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)
Prophylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV vaccines are safe, immunogenic, and exhibit robust p...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-03-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849738425355206656 |
|---|---|
| author | Society of Gynecologic Oncology, Chinese Medical Association Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation Committee on Cervical Cancer, China Anti-Cancer Association Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care |
| author_facet | Society of Gynecologic Oncology, Chinese Medical Association Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation Committee on Cervical Cancer, China Anti-Cancer Association Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care |
| author_sort | Society of Gynecologic Oncology, Chinese Medical Association |
| collection | DOAJ |
| description | Prophylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV vaccines are safe, immunogenic, and exhibit robust protective efficacy and effectiveness.Priority vaccination is recommended for females aged 9-26 years, with a focus on girls aged 9-14 years.Additionally, vaccination is advised for females aged 27-45 years and males aged 9-26 years to promote gender-neutral prevention strategies.Prophylactic HPV vaccination is also recommended for high-risk and special populations, including individuals with HPV infection or cytological abnormalities, those with a history of HPV-related lesions, genetically susceptible populations, individuals with high-risk lifestyle behaviors associated with cervical cancer, and immunocompromised patients.Regular cervical cancer screening remains essential post-vaccination. |
| format | Article |
| id | doaj-art-64e8ef19812e4278978c00207fe8f524 |
| institution | DOAJ |
| issn | 1674-9081 |
| language | zho |
| publishDate | 2025-03-01 |
| publisher | Editorial Office of Medical Journal of Peking Union Medical College Hospital |
| record_format | Article |
| series | Xiehe Yixue Zazhi |
| spelling | doaj-art-64e8ef19812e4278978c00207fe8f5242025-08-20T03:06:36ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812025-03-0116235036010.12290/xhyxzz.2025-0246Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)Society of Gynecologic Oncology, Chinese Medical AssociationBranch of Colposcopy and Cervical Pathology, China Healthy Birth Science AssociationProfessional Committee on Cancer Prevention and Control, Chinese Preventive Medicine AssociationSpecialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research AssociationNational Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer FoundationCommittee on Cervical Cancer, China Anti-Cancer AssociationBranch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health CareProphylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV vaccines are safe, immunogenic, and exhibit robust protective efficacy and effectiveness.Priority vaccination is recommended for females aged 9-26 years, with a focus on girls aged 9-14 years.Additionally, vaccination is advised for females aged 27-45 years and males aged 9-26 years to promote gender-neutral prevention strategies.Prophylactic HPV vaccination is also recommended for high-risk and special populations, including individuals with HPV infection or cytological abnormalities, those with a history of HPV-related lesions, genetically susceptible populations, individuals with high-risk lifestyle behaviors associated with cervical cancer, and immunocompromised patients.Regular cervical cancer screening remains essential post-vaccination.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0246human papilloma virusvaccinesclinical applicationhigh-riskspecial populations |
| spellingShingle | Society of Gynecologic Oncology, Chinese Medical Association Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation Committee on Cervical Cancer, China Anti-Cancer Association Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) Xiehe Yixue Zazhi human papilloma virus vaccines clinical application high-risk special populations |
| title | Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) |
| title_full | Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) |
| title_fullStr | Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) |
| title_full_unstemmed | Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) |
| title_short | Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition) |
| title_sort | preventive human papilloma virus vaccine guidelines for clinical use in china 2025 edition |
| topic | human papilloma virus vaccines clinical application high-risk special populations |
| url | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0246 |
| work_keys_str_mv | AT societyofgynecologiconcologychinesemedicalassociation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT branchofcolposcopyandcervicalpathologychinahealthybirthscienceassociation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT professionalcommitteeoncancerpreventionandcontrolchinesepreventivemedicineassociation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT specializedcommitteeoncervicalcancerpreventionandcontrolresearchchinamaternalandchildhealthresearchassociation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT nationalcollaborativegroupforcervicalcancerpreventionandtreatmentchinacancerfoundation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT committeeoncervicalcancerchinaanticancerassociation preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition AT branchofobstetricandgynecologicalhealthmedicinechinainternationalexchangeandpromotiveassociationformedicalandhealthcare preventivehumanpapillomavirusvaccineguidelinesforclinicaluseinchina2025edition |